Disrupting the status quo to achieve early inclusion of pregnant women in studies of new agents for prevention and treatment of HIV infection-Reference-Cited by-同舟云学术

Disrupting the status quo to achieve early inclusion of pregnant women in studies of new agents for prevention and treatment of HIV infection

Published:2022-07 Issue:S2 Volume:25 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc.

Author:

Abrams Elaine J.¹²,Penazzato Martina³^ORCID

Affiliation:

1. ICAP at Columbia University Mailman School of Public Health Columbia University New York New York USA

2. Vagelos College of Physicians and Surgeons Columbia University New York City New York USA

3. Global Programme on HIV, Hepatitis and Sexually Transmitted infections World Health Organization Geneva Switzerland

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25927

Reference31 articles.

1. United States Food & Drug Administration.FDA approves first injectable treatment for HIV pre‐exposure prevention. FDA News Release.2021. Available from:https://www.fda.gov/news‐events/press‐announcements/fda‐approves‐first‐injectable‐treatment‐hiv‐pre‐exposure‐prevention?fbclid=IwAR0mjAbhrBM9FwkasVDWzNZ8_kzhmhiD‐A00gf3E3k‐mn23wQVKETpX8bFMAccessed May 1 2022

2. HIV prevention: better choice for better coverage

3. Joint United Nations Programme on HIV/AIDS.Start Free Stay Free AIDS Free: final report on 2020 targets.2021. Available from:https://pedaids.org/wp‐content/uploads/2021/07/2021_start‐free‐stay‐free‐aids‐free‐final‐report‐on‐2020‐targets_en.pdf?msclkid=8fa8bcd4c20911ec87b7b67c80541ae5Accessed May 1 2022

4. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

5. Delany‐MoretlweS HughesJP GuoX HanscomB HendrixCW FarriorJ et al.CROI 2022 Abstract.2022. Available from:https://www.croiconference.org/abstract/evaluation‐of‐cab‐la‐safety‐and‐pk‐in‐pregnant‐women‐in‐the‐blinded‐phase‐of‐hptn‐084/Accessed May 1 2022